Codexis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.

CEO

Stephen George Dilly

CEOStephen George Dilly

Employees

188

Employees188

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2002

Founded2002

Employees

188

Employees188

CDXS Key Statistics

Market cap

241.47M

Market cap241.47M

Price-Earnings ratio

-3.52

Price-Earnings ratio-3.52

Dividend yield

—

Dividend yield—

Average volume

1.55M

Average volume1.55M

High today

$2.87

High today$2.87

Low today

$2.67

Low today$2.67

Open price

$2.87

Open price$2.87

Volume

928.43K

Volume928.43K

52 Week high

$6.08

52 Week high$6.08

52 Week low

$1.90

52 Week low$1.90

CDXS News

TipRanks 6d

Codexis: Strong Q2 Performance Amid Strategic Transition Justifies Hold Rating

Benchmark Co. analyst Robert Wasserman has maintained their neutral stance on CDXS stock, giving a Hold rating today. Elevate Your Investing Strategy: Take adva...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

People also own

Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.